NO965182L - Nye 1,1-bis(heteroazolyl)alkanderivater og deres anvendelse som neurobeskyttende midler - Google Patents

Nye 1,1-bis(heteroazolyl)alkanderivater og deres anvendelse som neurobeskyttende midler

Info

Publication number
NO965182L
NO965182L NO965182A NO965182A NO965182L NO 965182 L NO965182 L NO 965182L NO 965182 A NO965182 A NO 965182A NO 965182 A NO965182 A NO 965182A NO 965182 L NO965182 L NO 965182L
Authority
NO
Norway
Prior art keywords
heteroazolyl
bis
new
neuroprotective agents
alkane derivatives
Prior art date
Application number
NO965182A
Other languages
English (en)
Other versions
NO307421B1 (no
NO965182D0 (no
Inventor
Robin Bernard Boar
Duncan Alastair Gray
Dennis Mark O'shea
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO965182D0 publication Critical patent/NO965182D0/no
Publication of NO965182L publication Critical patent/NO965182L/no
Publication of NO307421B1 publication Critical patent/NO307421B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO965182A 1994-06-07 1996-12-04 Nye 1,1-bis(heteroazolyl)alkanderivater, farmasøytisk preparat inneholdende slike derivater, deres anvendelse, samt mellomprodukter NO307421B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401965A SE9401965D0 (sv) 1994-06-07 1994-06-07 New compounds
PCT/SE1995/000604 WO1995033747A1 (en) 1994-06-07 1995-05-29 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents

Publications (3)

Publication Number Publication Date
NO965182D0 NO965182D0 (no) 1996-12-04
NO965182L true NO965182L (no) 1996-12-04
NO307421B1 NO307421B1 (no) 2000-04-03

Family

ID=20394274

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965182A NO307421B1 (no) 1994-06-07 1996-12-04 Nye 1,1-bis(heteroazolyl)alkanderivater, farmasøytisk preparat inneholdende slike derivater, deres anvendelse, samt mellomprodukter

Country Status (26)

Country Link
US (2) US5843971A (no)
EP (1) EP0765325A1 (no)
JP (1) JPH10503172A (no)
CN (1) CN1051546C (no)
AU (1) AU691303B2 (no)
BR (1) BR9507923A (no)
CA (1) CA2190128A1 (no)
CZ (1) CZ357796A3 (no)
DZ (1) DZ1895A1 (no)
EE (1) EE9600197A (no)
FI (1) FI964879A (no)
HR (1) HRP950302A2 (no)
HU (1) HUT76050A (no)
IL (1) IL113773A (no)
IS (1) IS4383A (no)
MA (1) MA23574A1 (no)
NO (1) NO307421B1 (no)
NZ (1) NZ287973A (no)
PL (1) PL318470A1 (no)
RU (1) RU2155763C2 (no)
SE (1) SE9401965D0 (no)
SK (1) SK155696A3 (no)
TN (1) TNSN95065A1 (no)
WO (1) WO1995033747A1 (no)
YU (1) YU38695A (no)
ZA (1) ZA954145B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401965D0 (sv) * 1994-06-07 1994-06-07 Astra Ab New compounds
US6921538B2 (en) * 2002-05-10 2005-07-26 Allergan, Inc. Therapeutic treatments for neuropsychiatric disorders
US7649098B2 (en) * 2006-02-24 2010-01-19 Lexicon Pharmaceuticals, Inc. Imidazole-based compounds, compositions comprising them and methods of their use
TW200920355A (en) * 2007-09-06 2009-05-16 Lexicon Pharmaceuticals Inc Compositions and methods for treating immunological and inflammatory diseases and disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801794A1 (de) * 1978-01-17 1979-07-19 Basf Ag Verfahren zur herstellung von thiazolderivaten und neue thiazole
US5554620A (en) * 1993-09-14 1996-09-10 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof
SE9401965D0 (sv) * 1994-06-07 1994-06-07 Astra Ab New compounds

Also Published As

Publication number Publication date
NZ287973A (en) 1998-04-27
SE9401965D0 (sv) 1994-06-07
PL318470A1 (en) 1997-06-23
JPH10503172A (ja) 1998-03-24
MA23574A1 (fr) 1995-12-31
EP0765325A1 (en) 1997-04-02
US5665747A (en) 1997-09-09
HRP950302A2 (en) 1997-08-31
YU38695A (sh) 1998-12-23
FI964879A0 (fi) 1996-12-05
BR9507923A (pt) 1997-09-23
AU691303B2 (en) 1998-05-14
AU2685995A (en) 1996-01-04
ZA954145B (en) 1995-12-07
HUT76050A (en) 1997-06-30
EE9600197A (et) 1997-06-16
TNSN95065A1 (fr) 1996-02-06
NO307421B1 (no) 2000-04-03
RU2155763C2 (ru) 2000-09-10
DZ1895A1 (fr) 2002-02-17
CN1150426A (zh) 1997-05-21
FI964879A (fi) 1996-12-05
CZ357796A3 (en) 1997-06-11
NO965182D0 (no) 1996-12-04
IL113773A0 (en) 1995-08-31
IS4383A (is) 1996-11-12
WO1995033747A1 (en) 1995-12-14
US5843971A (en) 1998-12-01
CN1051546C (zh) 2000-04-19
HU9603386D0 (en) 1997-01-28
IL113773A (en) 2000-02-29
CA2190128A1 (en) 1995-12-14
SK155696A3 (en) 1997-05-07

Similar Documents

Publication Publication Date Title
NO982802L (no) Nye 5-amino-3-cyano-4-etylsulfinyl-1-fenyl-pyrazol-forbindelser og deres anvendelse som pesticider
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
NO986024L (no) Substituerte 3,5-difenyl-1,2,4-triazoler og deres anvendelse som farmas°ytiske metallchelatorer
NO962952L (no) 1,2,4-oksadiazolderivater og deres anvendelse som parasitticider for dyr
NO993003L (no) Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
NO963506D0 (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
DK0906292T3 (da) Triazolylmercaptider og deres anvendelse som mikrobicider
NO964654D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO960028L (no) Nye (1-heteroazolyl-1-heterocyclyl)alkanderivater og deres anvendelse som neurobeskyttende midler
DK0764157T3 (da) Benzopyraner og deres anvendelse som terapeutiske midler
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
NO20001288D0 (no) Substituerte 1,2,3,4,5,6-heksahydro-2,6-metano-3-benzazocin- 10-oler, fremgangsmÕte for fremstilling derav og anvendelse som legemiddel
NO960029L (no) Nye (1-fenyl-1-heterocyklyl)alkanderivater og deres anvendelse som neurobeskyttelsesmidler
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
NO965182L (no) Nye 1,1-bis(heteroazolyl)alkanderivater og deres anvendelse som neurobeskyttende midler
NO972256D0 (no) O-Benzyloksimeterderivater og deres anvendelse som pesticider
NO962951D0 (no) 3-arylalkenyl-1,2,4-oksadiazolderivater og deres anvendelse som parasitticider for dyr
NO964452D0 (no) Substituerte 5,6-dihydro-5-okso-1,4-ditiiono-(2,3-D)-pyridazin-2,3-dikarbonitriler, blandinger inneholdende dem og deres anvendelse som antimikrobemidler
DK0675681T3 (da) Arylamino-alkoiminoderivater og deres anvendelse som fungicider
DK1235809T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazociner og deres anvendelse som lægemidler
NO942322L (no) Nye 3-halogen-5-halogenmetyl-2-oksazolidinoner og deres anvendelse som mikrobicider
NO923042D0 (no) 4,5-cykloalkano-3-benzazepin-7-ol-derivater og deres anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002